Biomemory Launches DNA Shield for Offline Data Storage
The new service secures digital information in synthetic DNA to protect sensitive data from network-based cyber threats.
Updated on Oct. 26, 2026 in Cybersecurity
Live Poll
Do you trust emerging DNA-based technologies to keep sensitive institutional data secure long-term?
Biomemory has launched DNA Shield, an offline storage service that encodes digital information into synthetic DNA. The commercial service operates outside the active control plane to protect data from cyberattacks.
Why it matters
By moving information into synthetic biological molecules, this approach seeks to eliminate digital exposure for high-security datasets. It represents a shift toward using long-term molecular preservation to mitigate the vulnerability of traditional network-connected infrastructure.
Digital data is converted into synthetic DNA sequences and held in managed physical custody. The process is distinct from conventional storage as it functions entirely offline, sequestered from network-based attack vectors.
The players
Biomemory
A Paris and Boston-based firm specializing in synthetic DNA-based information storage and molecular computing.
Laurent Guengant
The Chief Executive Officer of Biomemory, responsible for overseeing the transition from research to commercial storage services.
Catalog Technologies
A former pioneer in DNA-based data storage and compute whose assets were integrated into Biomemory earlier this year.
The details
Customers encrypt their files before Biomemory encodes the information into a proprietary synthetic DNA strand. This physical medium is stored in a controlled environment to ensure longevity. When access is required, the company uses a specific retrieval process to decode the molecular structure back into digital format.
Timeline
Earlier in 2026, Biomemory acquired the assets of Catalog Technologies.
Laurent Guengant was appointed Chief Executive Officer during 2026.
Biomemory officially launched the DNA Shield service on October 26, 2026.
The Tech Race
Biomemory is pivoting from research into the commercial sector, leveraging the assets of Catalog Technologies to compete with traditional long-term archival systems. The company aims to evolve this platform beyond sovereign data protection into future molecular search and compute capabilities.
The service is currently targeted at institutions requiring sovereign data protection rather than immediate consumer-grade cloud integration. Users should monitor for future updates regarding the promised expansion into molecular search and compute workflows.
The takeaway
This launch signals a practical move toward using biological molecules for long-term data security rather than just scientific proof-of-concept. Prospective users should monitor Biomemory's upcoming milestones, specifically the planned expansion into molecular compute and search features.
Further reading
Learn more about the latest developments in Cybersecurity to understand how organizations are securing critical data.
Source note: This article includes information reported by SecurityBrief US.
Live Poll
Do you trust emerging DNA-based technologies to keep sensitive institutional data secure long-term?
